Company Nexstim Plc Nasdaq Helsinki
Equities
FI4000354162
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Navigated Brain Stimulation Systems
42.9
%
| 2 | 23.6 % | 3 | 42.9 % | +38.51% |
Navigated Brain Therapy Systems Continuous
27.4
%
| 2 | 18.3 % | 2 | 27.4 % | +13.58% |
Navigated Brain Stimulation Systems Continuous
16.3
%
| 1 | 12.3 % | 1 | 16.3 % | +0.52% |
Navigated Brain Therapy Systems
13.4
%
| 1 | 8.7 % | 1 | 13.4 % | +17.69% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
44.8
%
| 6 | 64.2 % | 3 | 44.8 % | -46.88% |
Rest of Europe
30.9
%
| 1 | 14.4 % | 2 | 30.9 % | +63.57% |
Finland
20.6
%
| 2 | 18.9 % | 1 | 20.6 % | -17.07% |
Other
3.6
%
| 0 | 2.5 % | 0 | 3.6 % | +8.90% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 47 | 18/14/18 | |
Director of Finance/CFO | 38 | 01/14/01 | |
Gustaf Järnefelt
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/08/01 |
Jarmo Laine
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/08/01 |
Hanna Kotola
LAW | General Counsel | - | 01/17/01 |
Henri Hannula
SAM | Sales & Marketing | 50 | 01/01/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 11/19/11 | |
Director/Board Member | 53 | 01/21/01 | |
Director/Board Member | 65 | 01/21/01 | |
Chairman | 61 | 11/19/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,765,562 | 3,462,766 ( 51.18 %) | 0 | 51.18 % |
Company contact information
![address Nexstim Plc](https://cdn.zonebourse.com/static/address/111327461.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+4.18% | 211B | |
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B |